FREQUENCY OF PULMONARY HYPERTENSION IN ASYMPTOMATIC β-THALASSEMIA MAJOR PATIENTS AND THE ROLE OF PHYSIOLOGICAL PARAMETERS IN EVALUATION

REFERENCES

• Higgs DR, Thein SL, Woods WG. The molecular pathology of the thalassaemias. In: Weatherall DJ, Clegg B, eds. The Thalassaemia Syndromes. 4th ed. Oxford, UK: Blackwell Science; 2001:133–191.
   Google Scholar
• Borgna-Pignatti C, Cappellini MD, De Stefano P, . Survival and complications in thalassemia. Ann N Y Acad Sci. 2005;1054:40–47.
   PubMed Web of Science ®Google Scholar
• Aessopos A, Farmakis D, Hatziliami A, . Cardiac status in well-treated patients with thalassemia major. Eur J Haematol. 2004;73:359–366.
   PubMed Web of Science ®Google Scholar
• Hahalis G, Alexopoulos D, Kremastinos DT, Zoumbos NC. Heart failure in beta-thalassemia syndromes: a decade of progress. Am J Med. 2005;118:957–967.
   PubMed Web of Science ®Google Scholar
• Du ZD, Roguin N, Milgram E, Saab K, Koren A. Pulmonary hypertension in patients with thalassemia major. Am Heart J. 1997;134:532–537.
   PubMed Web of Science ®Google Scholar
• Tam DH, Farber HW. Pulmonary hypertension and beta-thalassemia major: report of a case, its treatment, and a review of the literature. Am J Hematol. 2006;81:443–447.
   PubMedGoogle Scholar
• Aessopos A, Farmakis D. Pulmonary hypertension in beta-thalassemia. Ann N Y Acad Sci. 2005;1154:342–349.
   Google Scholar
• McLaughlin VV, Archer SL, Badesch DB, . American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009;53:1573–1619.
   PubMed Web of Science ®Google Scholar
• Littera R, La Nasa G, Derchi G, . Long-term treatment with oral sildenafil in a thalassemic patient with pulmonary hypertension. Blood. 2002;100:1516–1517.
   PubMedGoogle Scholar
• Derchi G, Forni GL, Formisano F, . Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies. Haematologica. 2005;90:452–458.
   PubMed Web of Science ®Google Scholar
• El-Beshlawy A, Youssry I, El-Saidi S, . Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy. Pediatr Hematol Oncol. 2008;25:734–743.
   Google Scholar
• Factor JM, Pottipati SR, Rappoport I, . Pulmonary function abnormalities in thalassemia major and the role of iron overload. Am J Respir Crit Care Med. 1994;149:1570–1574.
   PubMed Web of Science ®Google Scholar
• Dimopoulou I, Kremastinos DT, Maris TG, . Respiratory function in patients with thalassaemia and iron overload. Eur Respir J. 1999;13:602–605.
   PubMedGoogle Scholar
• Zakynthinos Z, Vassilakopoulos T, Kaltsas P, . Pulmonary hypertension, interstitial lung fibrosis, and lung iron deposition in thalassaemia major. Thorax. 2001;56:737–739.
   PubMedGoogle Scholar
• Wu KH, Chang JS, Su BH, Peng CT. Tricuspid regurgitation in patients with beta-thalassemia major. Ann Hematol. 2004;83:779–783.
   PubMedGoogle Scholar
• Miller MR, Hankinson J, Brusasco V, . ATS/ERS Task Force Standardisation of spirometry. Eur Respir J. 2005;26:319–338.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD. Updated 2005. Available at: http://www.goldcopd.org.
   Google Scholar
• Venkateshiah SB, Ioachimescu OC, McCarthy K, Stoller JK. The utility of spirometry in diagnosing pulmonary restriction. Lung. 2008;186:19–25.
   Google Scholar
• Macintyre N, Crapo RO, Viegi G, . Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26:720–735.
   PubMed Web of Science ®Google Scholar
• Ogilvie CM, Forster RE, Blakemore WS, Morton JW. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest. 1957;36:1–17.
   PubMed Web of Science ®Google Scholar
• Morris CR, Kuypers FA, Kato GJ, . Hemolysis-associated pulmonary hypertension in thalassemia. Ann N Y Acad Sci. 2005;1054:481–485.
   PubMed Web of Science ®Google Scholar
• Atiq M, Bana M, Ahmed US, . Cardiac disease in beta-thalassaemia major: is it reversible? Singapore Med J. 2006;47:693–696.
   PubMedGoogle Scholar
• El-Beshlawy A, Youssry I, El-Saidi S, . Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy. Pediatr Hematol Oncol. 2008;25:734–743
   PubMed Web of Science ®Google Scholar
• Aessopos A, Farmakis D, Deftereos S, . Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia. Ann Hematol. 2005;84:353–357.
   PubMed Web of Science ®Google Scholar
• Atichartakarn V, Likittanasombat K, Chuncharunee S, . Pulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disorders. Int J Hematol. 2003;78:139–145.
   PubMed Web of Science ®Google Scholar
• Phrommintikul A, Sukonthasarn A, Kanjanavanit R, Nawarawong W. Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia. Heart. 2006;92:1467–1472.
   PubMed Web of Science ®Google Scholar
• Derchi G, Formisano F, Lamagna M, . Incidence of pulmonary hypertension in haemoglobinopathic patients without left ventricular dysfunction. Blood. 2005;106:2691.
   Google Scholar
• Jing ZC, Xu XQ, Badesch DB, . Pulmonary function testing in patients with pulmonary arterial hypertension. Respir Med. 2009;103:1136–1142.
   PubMed Web of Science ®Google Scholar
• Proudman SM, Stevens WM, Sahhar J, Celermajer D. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment. Intern Med J. 2007;37:485–495.
   PubMed Web of Science ®Google Scholar
• Wells AU, Steen V, Valentini G. Pulmonary complications: one of the most challenging complications of systemic sclerosis. Rheumatology (Oxford). 2009;48(Suppl 3):iii40–iii44.
   Google Scholar
• Piatti G, Allegra L, Fasano V, . Lung function in β-thalassemia patients: a longitudinal study. Acta Haematol. 2006;116:25–29.
   PubMed Web of Science ®Google Scholar
• Cogliandro T, Derchi G, Mancuso L, . Under the auspices of the Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE); guideline recommendations for heart complications in thalassemia major. J Cardiovasc Med. 2008;9:515–525.
   Google Scholar